Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review

Table 3

Survivals: RFA combined with TACE versus RFA alone for HCC.

Author/year	𝑛; (TACE+RFA/RFA)	Tumor size (mean, cm); (TACE+RFA/RFA)	Overall survival (%); (TACE+RFA/RFA)	𝑃
Kitamoto et al. [49]/2003	10/16	3.9/3.4	ND
Wang et al. [50]/2007	43/40	ND	68.3/57.6 (1-year)	<.05
Shibata et al. [51]/2009	46/43	ND	84.8/84.5 (3-year)	.515
Morimoto et al. [52]/2010	19/18	3.6/3.7	93/80 (3-year)	.369
Peng et al. [47]/2010	120/120	ND	50/42 (5-year)	.045

HCC: hepatocellular carcinoma; ND: not described; RFA: radiofrequency ablation, TACE: trans catheter arterial chemoembolization.